Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shane M who wrote (46459)	4/20/2012 4:45:27 PM
From: Paul Senior	Read Replies (1) of 78774

Shane, regarding HITK, I agree with Jurgis Bekepuris that this pharmaceutical company's losses in '07, '08 are a concern. Even with the stock now down from ytd highs (i.e. from $43 to $33), I still don't see it as value stock with a margin-of-safety. However, IF the company could maintain its current very good profit margins and ROE (which the company has not been able to do in past), then the stock should do okay. Seems to have plenty of cash and negligible ltd, so that helps. I'll go for a few shares here for a spec. While HITK does fall into my value box on it's current good numbers, its history is not so encouraging. advfn.com phx.corporate-ir.net

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next